The ESMO Breast Cancer is a congress organized by the European Society of Medical Oncology, designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care. It is a multidisciplinary meeting with a global scope, bringing together the community of experts and advocates presenting and discussing the latest ground-breaking developments in breast oncology and forging powerful new partnerships

Menarini Silicon Biosystems will be attending the ESMO Breast Cancer Congress 2025, an event focused on the latest developments in the science and clinical management of breast cancer.
The congress brings together oncologists, researchers, and healthcare professionals from around the world to share data, clinical experiences, and research findings aimed at improving breast cancer care.
Menarini Silicon Biosystems’s Medical Affairs team will be available at the booth throughout the congress to discuss the role of liquid biopsy technologies in advancing precision oncology for breast cancer.
To arrange a meeting during the congress, please contact us using the following link:
READ MORE